全文获取类型
收费全文 | 2051839篇 |
免费 | 158750篇 |
国内免费 | 7653篇 |
专业分类
耳鼻咽喉 | 27314篇 |
儿科学 | 66263篇 |
妇产科学 | 57011篇 |
基础医学 | 284800篇 |
口腔科学 | 56494篇 |
临床医学 | 180624篇 |
内科学 | 416762篇 |
皮肤病学 | 46886篇 |
神经病学 | 167062篇 |
特种医学 | 83761篇 |
外国民族医学 | 596篇 |
外科学 | 321583篇 |
综合类 | 47003篇 |
现状与发展 | 2篇 |
一般理论 | 637篇 |
预防医学 | 159611篇 |
眼科学 | 44911篇 |
药学 | 145423篇 |
5篇 | |
中国医学 | 3723篇 |
肿瘤学 | 107771篇 |
出版年
2018年 | 20476篇 |
2016年 | 18560篇 |
2015年 | 20980篇 |
2014年 | 29635篇 |
2013年 | 44907篇 |
2012年 | 56878篇 |
2011年 | 60826篇 |
2010年 | 37698篇 |
2009年 | 36440篇 |
2008年 | 57399篇 |
2007年 | 61322篇 |
2006年 | 62340篇 |
2005年 | 60769篇 |
2004年 | 57984篇 |
2003年 | 56438篇 |
2002年 | 54301篇 |
2001年 | 96582篇 |
2000年 | 99496篇 |
1999年 | 83680篇 |
1998年 | 24522篇 |
1997年 | 22113篇 |
1996年 | 22829篇 |
1995年 | 22455篇 |
1994年 | 21104篇 |
1993年 | 19750篇 |
1992年 | 68222篇 |
1991年 | 65953篇 |
1990年 | 63908篇 |
1989年 | 61056篇 |
1988年 | 56687篇 |
1987年 | 55648篇 |
1986年 | 52899篇 |
1985年 | 50837篇 |
1984年 | 38581篇 |
1983年 | 32621篇 |
1982年 | 20164篇 |
1981年 | 17929篇 |
1980年 | 16983篇 |
1979年 | 35038篇 |
1978年 | 25124篇 |
1977年 | 21194篇 |
1976年 | 19665篇 |
1975年 | 20960篇 |
1974年 | 24832篇 |
1973年 | 23709篇 |
1972年 | 22239篇 |
1971年 | 20490篇 |
1970年 | 19017篇 |
1969年 | 17899篇 |
1968年 | 16843篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
62.
63.
M. Parikh M.D. J. Duncombe M.B. B.S. G.A. Fielding M.D. 《Surgery for obesity and related diseases》2006,2(5):99-522
BACKGROUND: Many mild-to-moderately obese individuals (body mass index [BMI] 30-35 kg/m(2)) have serious diseases related to their obesity. Nonoperative therapy is ineffective in the long term, yet surgery has never been made widely available to this population. METHODS: Between 1996 and 2004, 93 patients with a BMI of 30-35 kg/m(2) underwent laparoscopic adjustable gastric banding with the LAP-BAND. All patients were referred by their primary physician, entered into a comprehensive bariatric surgery program at one Australian center, and operated on by one surgeon. Data on all patients were collected prospectively and entered into an electronic registry. The study parameters included preoperative age, gender, BMI, presence of co-morbidities, percentage of excess weight loss, and resolution of co-morbidities. RESULTS: The mean age was 44.6 years (range 16-76), mean weight was 98 kg, and the mean BMI was 32.7 kg/m(2) (range 30-34). Of the 93 patients, 42 (45%) had co-morbidities, including asthma, diabetes, hypertension, and sleep apnea. The proportion of patients in follow-up was 79%, 85%, and 89% at 1, 2, and 3 years, respectively. The mean weight was reduced to 71 kg at 1 year, 72 kg at 2 years, and 72 kg at 3 years. The mean BMI was reduced to 27.2 +/- 2.2, 27.3 +/- 3.1, and 27.6 +/- 3.7 kg/m(2), respectively, and the mean percentage of excess weight loss was 57.9% +/- 24.5%, 57.6 +/- 29.3%, and 53.8% +/- 32.8% at 1, 2, and 3 years, respectively. At 3 years, the BMI was 18-24 kg/m(2) in 34%, 25-29 kg/m(2) in 51%, and 30-35 kg/m(2) in 10%. At 3 years, the percentage of excess weight loss was <25% in 10%, 25-50% in 24%, 50-75% in 51%, and >75% in 10%. The co-morbidities improved or completely resolved in most patients. No mortality occurred. CONCLUSION: We are very encouraged by this series of low BMI patients treated with the LAP-BAND. Their weight loss has been good, the complications have been minimal, and the co-morbidities have partially or wholly resolved. With additional study, it is reasonable to expect the weight guidelines for bariatric surgery to be altered to include patients with a BMI of 30-35 kg/m(2). 相似文献
64.
65.
66.
67.
68.
69.
70.